Thursday, April 03, 2014
“We are really excited that the trial is about to start because there has been so much work to get to this point. We are also apprehensive even though we are pretty confident the results will be good.”
In the lead up to the SONIA 2 clinical trials the Daily Mail reports on Nick’s story and spreads the word about alkaptonuria (AKU).
The drug being tested is called Nitisinone. If the trials are successful it could mean Nick’s sons and many other sufferers will never have to face the severe symptoms of this progressive disease. Read the full article online.